Peptide Therapy

BPC-157 is a pentadecapeptide made up of 15 amino acids.

Potential Benefits: Experiments have shown that it heightens the healing of many different types of tissues, including: tendon, muscle, nervous system, + is superior at healing damaged ligaments.

Those who suffer from pain due to sprains, tears, + tissue damage may benefit from BPC 157 as it can increase blood flow to the injured sites.

BPC-157 may protect organs, prevent stomach ulcers, and heal skin burns.

Common Protocol: Often based on body weight using 2mcg/kg to as much as 10mcg/kg twice daily.

• Doses commonly range from 200mcg to 1mg once-twice daily.

• If used twice daily, intramuscular injection as close to the injury as possible or via subcutaneously for systemic purposes. Oral supplementation is more for gastrointestinal support.

• Used for 2-4 weeks before discontinuing for 2 weeks, then restarting therapy as needed.

Thymosin is a hormone secreted from the thymus.Its primary function is to stimulate the production of T cells, which are an important part of the immune system. Thymosin also assists in the development of B cells to plasma cells to produce antibodies. The predominant form of Thymosin, Thymosin Beta 4, is a member of a highly conserved family of actin monomer-sequestering proteins. In addition to its role as a major actin-sequestering molecule, Thymosin Beta 4 plays a role in tissue repair. Tß4 has been found to play an important role in protection, regeneration and remodeling of injured or damaged tissues. The gene for Tß4 has also been found to be one of the first to be upregulated after injuries. Thymosin Beta 4 is currently being trialed as a potential therapy for HIV, AIDS, and Infl uenza. Thymosin Beta 4 is most often prescribed for acute injury, surgical repair and for senior athletes. It has most recently been shown to help regrow hair in addition to PRP.

GHK-Cu (glycyl-l-histidyl-l-lysine) is a small, naturally occurring tri-peptide present in human plasma that also can be released from tissues in case of an injury.

Potential Benefits: Studies have shown that copper peptide promotes the production of collagen + elastin to firm + plump aging skin. It also acts as an antioxidant + promotes production of glycosaminoglycans (such as hyaluronic acid). Reduces fine lines, depth of wrinkles, smooths rough skin, reduces photo-damaged, mottled hyperpigmentation, skin spots + lesions. Increases hair growth + thickness, + enlarges hair follicle size.

Common Protocol: As a cream or topical solution, 1-2mg can be applied daily to desired areas of treatment. As a scalp foam, 4-6mg nightly.

Sermorelin is another powerful peptide used to help augment human growth hormone (HGH) production. Just like ipamorelin, sermorelin is a growth hormone peptide, but it works differently in the body by stimulating GHRH instead of ghrelin. This stimulates growth hormone release from the pituitary gland. Benefits of sermorelin therapy include decreased body fat, increased endurance and strength, increased lean muscle mass, and improved sleep.

CJC-1295 is a tetrasubstituted 29-amino acid Growth Hormone Releasing Hormone (GHRH) analog. It stimulates a release of HGH and IGF-1 without raising prolactin levels, leading to fat loss and increased protein synthesis thereby promoting growth of muscle. Our CJC-1295 is compounded without DAC (Drug Affinity Complex) which provides a more effective GH spike resembling a normal physiologic release of GH. Ipamorelin Acetate is a Growth Hormone Releasing Peptide (GHRP) that assists increasing the amount of growth hormone released. Ipamorelin is a pentapeptide composed of five amino acids and has a biological half-life of 2 hours after administration. It is widely known for being able to suppress somatostatin or Growth Hormone Inhibiting Hormone (GHIH). Using CJC-1295 in conjunction with Ipamorelin may be more effective in the production of growth hormone secretion, and in helping speed recovery time after an injury.

Ipamorelin Acetate is a Growth Hormone Releasing Peptide
(GHRP) that assists in increasing the amount of growth hormone
released. The four most common GHRPs are Ipamorelin, GHRP-2, GHRP-6, and Hexarelin – in order of strength.

Potential Benefits: Promotes slow wave sleep, improves memory retention, stimulates muscle growth, aids in fat loss + lean muscle.

Common Protocol: Ipamorelin stacked with Sermorelin + Theanine as sublingual tablet 180mcg taken before bed or at least 30 minutes away from food. Those with a higher BMI or high estrogen levels may require larger doses.

Suggested Add-on: AOD 9604 for enhanced weight loss

Tesamorelin is a growth hormone releasing hormone analog that increases IGF-1 levels in men and women by an average of 181 micrograms/liter. It binds to and stimulates GHRH receptors with similar potency as endogenous GHRH. It has a host of other benefits including nootropic effects and reducing triglycerides. Tesamorelin has subsequently been shown to decrease carotid intima-media thickness (cIMT), visceral adipose tissue (VAT), and c-reactive protein (CRP). It has not been linked to significantly affect other pituitary hormones and their respective mechanisms in the body. Additionally, it may improve cognitive function for healthy seniors and patients with an increased risk of Alzheimer’s disease, due to mild cognitive impairment.

Tirzepatide serves as an analogue to GIP. It activates both GLP-1 and GIP receptors to stimulate insulin release from the pancreas, which results in improved blood sugar control.

What makes this peptide unique is its ability to activate these receptors simultaneously, enhancing its therapeutic potential and offering comprehensive blood sugar control. This robust dual-action mechanism sets Tirzepatide apart from conventional diabetes medications, allowing it to offer improved glycemic control and additional benefits such as weight management.

Potential Benefits: improve blood glucose levels, lower A1C, promote lipolysis, reduce BMI, and stimulate pancreatic insulin release

Tirzepatide may also have side effects, like nausea and diarrhea. However, research has shown that these side effects can be managed effectively. The inclusion of compounds such as BPC-157 and Pyridoxine (B6) has been found to decrease these adverse effects. Moreover, most side effects are likely to decrease over time as the body adjusts to the medication.

Common Protocol: 1 injection weekly for 3-6 months or longer. Blood tests done monthly for at least 2 months.

MOTS-c is a mitochondrial-derived peptide (MDP) synthesized in response to cellular energy demands—particularly when glucose is scarce or when the body is under stress. Its primary mechanism is activating AMPK (AMP-activated protein kinase), a master regulator of cellular energy.

Potential Benefits: Energy, fat metabolism (especially glucose & fat), anti-oxidant, anti-aging, insulin sensitivity, enhanced exercise performance/recovery, with potential applications in metabolic diseases like type 2 diabetes.

Common Protocol: subcutaneous injection 2-3 times per week (e.g., Monday, Wednesday, Friday). with cycles ranging from 2 to 4 weeks for 1-3 months, depending on goals—fat loss, performance enhancement, or metabolic reset.

AOD 9604 is a fragment of human growth hormone (HGH) specifically designed to promote fat breakdown (lipolysis) and inhibit the formation of new fat tissue (lipogenesis) without the typical growth hormone effects like muscle growth. It works directly on fat cells to reduce body fat, making it a popular choice for weight loss. AOD 9604 does not affect insulin sensitivity or blood sugar levels, making it a safer alternative for fat loss than HGH itself.

PT-141 was developed from the peptide Melanotan 2, which is a synthetically produced variant of a peptide hormone naturally produced
in the body that stimulates melanogenesis.

PT-141 can help women ‘s libido + to achieve orgasm + male erectile dysfunction or impotence. Studies have shown that PT-141 does not act on the vascular system, but may increase sexual desire through the nervous system.

It works in 80% of men who don’t respond to PDE5 inhibitors + most now use it as first-line therapy.

Side effects include nausea, flushing, + headache.

Common Protocol via Nasal Spray:
1-2mg/dose or 1-2 sprays per nostril, at least one hour before the desired effect. It can be increased if results aren’t seen, but side effects such as nausea will be dose-dependent. Recommended to use no more than two times per week.

KPV contains the active bioregulator fragment of α-melanocyte stimulating hormone (α-MSH), which is considered to be one of the body’s most potent regulators of normal immune balance and mast cell system stimulation. It can treat a wide variety of inflammatory conditions, including Inflammatory Bowel Diseases (IBD) Ulcerative Colitis and Crohn’s Disease.
It can improve skin health and is used in healing wounds & injuries.

SEMAX (MEHFPGP) is the analogue
of ACTH (4-10) that has prolonged neurotropic activity. This has historically been used in people with brain circulation dysfunction.

Potential Benefits: Semax primes the brain for action, which can lead to a reduction of behaviors like avoidance + procrastination. Semax may also induce a controlled state of mental stress, which can optimize of brain function. It may help with ADHD, high intensity exercise, prevent oxidative damage, improve blood circulation, reduce anxiety + depression, + ease pain.

Common Protocol: 750mcg Nasal Spray once daily x 10 days.

Selank is a synthetic peptide with anti-anxiety and cognitive-enhancing properties. It works by modulating GABA and serotonin levels, providing anxiolytic effects without sedation. Selank also has immunomodulatory properties, helping the body cope with stress-related immune suppression, and improves memory and learning by boosting cognitive function.

Thymogen alpha-1’s primary role is to improve immune system function by stimulating and coordinating various molecules and pathways in the immune system. Through this, it may help with a variety of conditions, including the following, inflammation reduction, Type 1 Diabetes, pancreatitis.

DIHEXA is a peptide variant derived from angiotensin IV. Clinical studies suggest that DIHEXA improves cognitive function, such as Alzheimer’s. Angiotensin IV is a derivative of the vasoconstrictor angiotensin II which has been shown in animal studies to enhance acquisition, consolidation and recall of learning and memory when administered centrally or peripherally. In an assay of neurotrophic activity, DIHEXA was found to be seven orders of magnitude more potent than brain-derived neurotrophic factor and is thought may be able to help in the repair of the brain and nerves in neurological disease.

DSIP is a naturally occuring somnogenic nonapeptide with possible physiological functions impacting neuromodulation, commonly used for sleep support. DSIP is typically found in the brain and easily passes the blood-brain barrier. Studies indicate that DSIP and its analogues are best classified as peptide neuromodulators. DSIP has been shown to exhibit a pronounced stress protective action and demonstrated a decrease in stress induced metabolic disorders in both human and animal models. It is believed that DSIP works by modulating activity of GABAergic, glutamatergic, and other neuronal systems.